scispace - formally typeset
Y

Yonat Shemer-Avni

Researcher at Ben-Gurion University of the Negev

Publications -  60
Citations -  2623

Yonat Shemer-Avni is an academic researcher from Ben-Gurion University of the Negev. The author has contributed to research in topics: Virus & Human metapneumovirus. The author has an hindex of 25, co-authored 58 publications receiving 2169 citations. Previous affiliations of Yonat Shemer-Avni include Soroka Medical Center.

Papers
More filters
Journal ArticleDOI

Copper Oxide Impregnated Textiles with Potent Biocidal Activities

TL;DR: Data is described showing that antifungal socks containing 10% w/w (weight/weight) copper-impregnated fibers alleviate athlete’s foot; antimicrobial fabrics (sheets) containing 10%, decrease bacterial colonization in a clinical setting; and these products do not have skin-sensitizing properties or any other adverse effects, demonstrate the wide preventive and curative potential of copper oxide-Impregnated apparel products.
Journal ArticleDOI

Comparison of human metapneumovirus, respiratory syncytial virus and influenza A virus lower respiratory tract infections in hospitalized young children.

TL;DR: The clinical pattern of HMPV more closely resembles that of RSV than that of influenza A LRI, yet the differences in age, radiographic findings and clinical diagnosis suggest that H MPV pathogenesis may differ from that ofRSV.
Journal ArticleDOI

Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers.

TL;DR: P-BEST is developed, a method for Pooling-Based Efficient SARS-CoV-2 Testing, which identifies all positive subjects within a set of samples using a single round of testing, providing both an eightfold increase in testing efficiency and a eightfold reduction in test costs.
Journal ArticleDOI

SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera.

TL;DR: In this paper, neutralization potency of convalescent or Pfizer-BTN162b2 post-vaccination sera against pseudoviruses displaying spike proteins derived from wild-type SARS-CoV-2, or its UK-B.1.7 and SA-B1.351 variants were monitored.
Journal ArticleDOI

Global genetic diversity of human metapneumovirus fusion gene.

TL;DR: This work analyzed 64 human metapneumovirus strains from eight countries and identified two groups (A and B, amino acid identity 93%–96%) and four subgroups, although group A strains predominated, accounting for 69% of all strains.